NEW YORK (GenomeWeb News) – Bioinformatics firm Advaita said this week that it has been awarded up to $2.0 million by the National Institutes of Health to develop software for analyzing next-generation sequencing data for personalized medicine applications.

Advaita was awarded a Fast Track Small Business Investigation Research Phase I and II grant by the National Institute of General Medical Sciences to develop advanced software that leverages the Plymouth, Michigan-based firm's pathway analysis software called Pathway-Guide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.